Literature DB >> 11078984

Evolution of clinical symptoms in a young woman with a recurrent gonadotroph adenoma causing ovarian hyperstimulation.

I Pentz-Vidovíc1, T Skorić, G Grubisić, M Korsíc, T Ivicevic-Bakulic, N Besenski, J Paladino, V Plavsic, K Zarković.   

Abstract

OBJECTIVE: To demonstrate the clinical course in a young female with gonadotroph adenoma causing ovarian stimulation. PATIENT AND METHODS: Our patient was a 23-year-old woman with a history of oligomenorrhea who had previously undergone bilateral ovarian wedge resection owing to the clinical appearance of polycystic ovaries. Two years later, she sought treatment for headache, galactorrhea, history of spotting and lower abdominal distension. FSH, LH, beta-LH, inhibin A and B, estradiol, prolactin (PRL), and beta-chorionic gonadotrophin (beta-CG) were measured, and the responses of FSH, LH and beta-LH to thyrotrophin-releasing hormone (TRH) were documented. Immunohistochemical analysis of the tumor tissue was performed after surgery. Five years after the trans-sphenoidal surgery, the patient again became oligomenorrheic. A large recurrent adenoma was diagnosed on CT one year later. Transvaginal ultrasound showed ovaries of normal size with multiple small cystic formations simulating a polycystic pattern, While the patient was awaiting surgery, a pituitary apoplexy occurred. Emergency decompressive surgery was performed and the patient fully recovered.
RESULTS: Enlarged ovaries were found on ultrasound examination simulating a hyperstimulation-like pattern. At that time, elevated levels of FSH (13.4IU/l) and marginally elevated levels of beta-LH (1.43ng/ml) were found, whereas the level of LH (0.5IU/l) was subnormal. Plasma estradiol was markedly supranormal (6150pmol/l). Levels of inhibin A and B were elevated (326pg/ml and 588pg/ml respectively). The prolactin level (70ng/ml) was increased, whereas beta-chorionic gonadotrophin (beta-CG) was normal. Significantly increased FSH, LH, and beta-LH responses to TRH stimulation were documented. Pituitary macroadenoma was found on MRI scan and removed by trans-sphenoidal surgery. Immunohistochemical examination showed high positivity for beta-CG and LH, and slight positivity for FSH. Five years after the surgery, estradiol was elevated (1160pmol/l), whereas basal levels of LH (4.65IU/l) and FSH (3.98IU/l) were not suppressed. After the second operation, immunostaining of the adenoma tissue confirmed the previous findings.
CONCLUSIONS: Measurement of gonadotrophins in our case did not prove to be a method for identifying a large recurrent gonadotroph pituitary adenoma. The sonographic ovarian imaging varied from a polycystic- to an ovarian hyperstimulation-like pattern during the evolution of the tumour.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11078984     DOI: 10.1530/eje.0.1430607

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  9 in total

Review 1.  Functional Gonadotroph Adenomas: Case Series and Report of Literature.

Authors:  David J Cote; Timothy R Smith; Courtney N Sandler; Tina Gupta; Tejus A Bale; Wenya Linda Bi; Ian F Dunn; Umberto De Girolami; Whitney W Woodmansee; Ursula B Kaiser; Edward R Laws
Journal:  Neurosurgery       Date:  2016-12       Impact factor: 4.654

2.  Ovarian hyperstimulation syndrome due to follicle-stimulating hormone-secreting pituitary adenomas.

Authors:  Amelia Caretto; Roberto Lanzi; Cecilia Piani; Michela Molgora; Pietro Mortini; Marco Losa
Journal:  Pituitary       Date:  2017-10       Impact factor: 4.107

3.  Ovarian hyperstimulation syndrome caused by an FSH-secreting pituitary adenoma.

Authors:  Odelia Cooper; Jordan L Geller; Shlomo Melmed
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2008-02-12

4.  FOLLICLE-STIMULATING HORMONE-PRODUCING PITUITARY ADENOMA: A CASE REPORT AND REVIEW OF THE LITERATURE.

Authors:  Sonal Patel; Donato Pacione; Ilene Fischer; Ekrem Maloku; Nidhi Agrawal
Journal:  AACE Clin Case Rep       Date:  2019-04-25

5.  Molecular analysis of a mutated FSH receptor detected in a patient with spontaneous ovarian hyperstimulation syndrome.

Authors:  Sayaka Uchida; Hiroshi Uchida; Tetsuo Maruyama; Takashi Kajitani; Hideyuki Oda; Kaoru Miyazaki; Maki Kagami; Yasunori Yoshimura
Journal:  PLoS One       Date:  2013-09-13       Impact factor: 3.240

6.  Follicle-stimulating hormone-secreting pituitary adenoma manifesting as recurrent ovarian cysts in a young woman--latent risk of unidentified ovarian hyperstimulation: a case report.

Authors:  Tomohiro Kawaguchi; Yoshikazu Ogawa; Kenji Ito; Mika Watanabe; Teiji Tominaga
Journal:  BMC Res Notes       Date:  2013-10-11

7.  Spontaneous ovarian hyperstimulation syndrome revealing a pituitary macroadenoma.

Authors:  Ibtissem Oueslati; Karima Khiari; Néjib Ben Abdallah
Journal:  Indian J Endocrinol Metab       Date:  2016 Sep-Oct

Review 8.  Updating the Landscape for Functioning Gonadotroph Tumors.

Authors:  Georgia Ntali; Cristina Capatina
Journal:  Medicina (Kaunas)       Date:  2022-08-08       Impact factor: 2.948

9.  Follicle-Stimulating Hormone-Secreting Pituitary Adenoma Inducing Spontaneous Ovarian Hyperstimulation Syndrome, Treatment Using In Vitro Fertilization and Embryo Transfer: A Case Report.

Authors:  Xiaofang Du; Wen Zhang; Xingling Wang; Xiaona Yu; Zhen Li; Yichun Guan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-24       Impact factor: 5.555

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.